04th week of 2011 patent applcation highlights part 37 |
Patent application number | Title | Published |
20110020438 | Crystallization Inhibitor and Its Use in Gelatin Capsules - The present invention describes soft gelatin capsules that encapsulate a water-insoluble active ingredient and an excipient composed of a crystallization inhibitor that stabilizes the water-insoluble inhibitor. The crystallization inhibitor being at least one mononacylglycerol compound whose acyl group is a fatty acid residue of 6-18 carbon atoms. The capsule contents are more resistant to turbidity, forming a coarse emulsion, and crystallization of the active ingredient compared with compositions absent the crystallization inhibitor. | 2011-01-27 |
20110020439 | DELAYED RELEASE COMPOSITIONS OF DULOXETINE - A delayed release dosage form comprising core comprising duloxetine or its pharmaceutically acceptable salts or derivatives thereof, optionally, other pharmaceutically acceptable excipient(s) thereof; intermediate layer; and enteric layer; wherein the dosage form comprises one/more dissolution enhancer(s), wherein the enteric layer comprises one/more enteric polymers other than hydroxypropylmethyl acetate succinate. A process of preparing a delayed release dosage comprising mixing pharmaceutically acceptable excipients with duloxetine or its pharmaceutically acceptable derivatives thereof; granulating the product of previous step compressing the granulate formed in previous step to form core, coating said core with intermediate layer followed by coating with one/more enteric polymers and optional finishing coating. A delayed release dosage form comprising: core comprising duloxetine or its pharmaceutically acceptable derivative thereof, intermediate layer and enteric layer comprising one/more enteric polymers other than hydroxypropylmethyl acetate succinate; wherein dosage form contains one/more dissolution enhancer(s) and has improved dissolution. | 2011-01-27 |
20110020440 | STABLE SOLUTIONS OF SPARINGLY SOLUBLE ACTIVES - The present invention relates to a stable pharmaceutical composition comprising soft gelatin capsules containing at least one sparingly soluble active drug (singly or in combination with sparingly soluble and/or soluble drugs) and a solvent system, wherein the solvent system comprises of solvent, co-solvent, solubilizer(s), surfactant, aqueous solution of alkali and crystal growth inhibitor. The present invention further relates to process for preparing a stable pharmaceutical composition of sparingly soluble active drug(s) in soft gelatin capsules. | 2011-01-27 |
20110020441 | USE OF 5-AMINOLEVULINIC ACID AND DERIVATIVES IN A SOLID FORM FOR PHOTODYNAMIC TREATMENT AND DIAGNOSIS - The present invention relates to the use of a photosensitiser which is 5-ALA or a precursor or derivative thereof (e.g. an ALA ester), in the manufacture of a pharmaceutical product for use in the photodynamic treatment or diagnosis of cancer, an infection associated with cancer, or in the treatment or diagnosis of a non-cancerous condition, wherein said pharmaceutical product is in the form of a solid. The invention also relates to solid pharmaceutical products for use in such methods, e.g. suppositories, pessaries, tablets, pellets and capsules which comprise 5-ALA or a precursor or derivative thereof (e.g. an ALA ester) and at least one pharmaceutically acceptable carrier or excipient. Such products are particularly suitable for use in the photodynamic treatment or diagnosis of cancerous or non-cancerous conditions in the lower part of the gastrointestinal system or in the female reproductive system, e.g. in the treatment or diagnosis of colorectal cancer or cervical cancer. | 2011-01-27 |
20110020442 | Taste Masked Oral Composition of Telithromycin - The invention relates to an oral compositions comprising telithromycin that have taste masking properties, a process for the preparation thereof, and methods of using the composition. | 2011-01-27 |
20110020443 | SLOW RELEASE MAGNESIUM COMPOSITION AND USES THEREOF - The present invention provides compositions that contain magnesium and threonate, or a threonate precursor molecule, formulated for extended or modified release to provide physiological concentrations over a desired time period. The extended release or modified release form is particularly useful in providing Mg to a subject while avoiding adverse side effects such as diarrhea. | 2011-01-27 |
20110020445 | EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS OF LEVETIRACETAM - Extended release pharmaceutical compositions of levetiracetam or pharmaceutically acceptable salts thereof in the form of a tablet comprising glyceryl behenate and a polymethacrylate polymer with at least one pharmaceutically acceptable excipient. | 2011-01-27 |
20110020446 | METHODS AND FORMULATIONS FOR MAKING PHARMACEUTICAL COMPOSITIONS CONTAINING BUPROPION - Embodiments of the invention generally provide pharmaceutical drug compositions, methods of preparing oral drug compositions, such as extended release dosage compositions, and methods for treating antidepressant or smoking cessation. In one aspect, the invention provides a pharmaceutical formulation comprising a core, including bupropion and its salt derivatives, and a coating. The coating may include from about 5% to about 99% by weight of the coating of a pharmaceutically acceptable pH-independent polymer. The coating may further include from about 0.001% to about 30% by weight of the coating of a surfactant. In another aspect, the invention provides methods for preparing and administering a pharmaceutical composition in oral dosage form, such as a tablet. | 2011-01-27 |
20110020447 | NOVEL DOSAGE FORM - The present invention relates to a novel dosage form, to a process for preparing the dosage form and to the use of the dosage form in the treatment of neurological and psychiatric disorders. | 2011-01-27 |
20110020448 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF GLAUCOMA - Provided is a pharmaceutical composition for the treatment and prevention of glaucoma, containing (a) a therapeutically effective amount of a compound represented by Formula 1 or a pharmaceutically acceptable salt, prodrug, solvate or isomer thereof, and (b) a pharmaceutically acceptable carrier, diluent or excipient or any combination thereof. | 2011-01-27 |
20110020449 | METHODS OF TREATING DISORDERS OF THE EYE AND SURROUNDING TISSUE WITH THYMOSIN BETA 4 (TB4), ANALOGUES, ISOFORMS AND OTHER DERIVATIVES - Pain or irritation of the eyes, caused by injury due to dry eye syndrome, chemical burns or the like can be accompanied by corneal stromal edema. It has been discovered that administration of thymosin β4 and/or oxidized thymosin β4 to cornea in need of treatment of corneal stromal edema is a useful treatment for decreasing such corneal stromal edema. | 2011-01-27 |
20110020450 | TITRATABLE DOSAGE TRANSDERMAL DELIVERY SYSTEM - The present invention relates to a titratable dosage transdermal delivery system for systemic delivery of a therapeutic agent or drug. The system comprises a plurality of patch units that are connected along one or more borders. The plurality of patch units are divisible into units along the one or more borders having one or more lines of separation. Each patch unit is surrounded by a border. The therapeutic patch has at least a backing layer and a therapeutic agent comprising layer. The dosage of therapeutic agent delivered to a patient is proportional to the number of patch unit applied per treatment. The system enables systemic administration of a titratable dosage of therapeutic agent, adjustable by the patient under the direction of a physician, through the skin or mucosa. Moreover, the invention relates to a method of making the titratable dosage transdermal delivery system. Furthermore, the invention relates to a method of providing a titratable amount of therapeutic agent to a patient using the transdermal delivery system of the invention. | 2011-01-27 |
20110020452 | PROGENITOR CELL REPLICATION AND DIFFERENTIATION IN 3D - The present invention is directed to a new approach towards in situ differentiation of tissue progenitor cells, without the coventional requirements of weeks of cellular manipulation and treatment. Such approach circumvents the need for 2D culturing and differentiation of tissue progenitor cells before implanting in a 3D biocompatible matrix, thus providing convenience, cost savings, and time savings. One aspect of the invention provides an engineered tissue composition comprising substantially undifferentiated tissue progenitor cells in a biphasic matrix material, along with growth factors or encapsulated growth factors. Another aspect of the invention includes methods for making the compositions described herein. Another aspect of the invention includes methods of therapeutic treatment using the compositions described herein. | 2011-01-27 |
20110020453 | Topical Formulations Comprising Ion Channel Modulators - Disclosed herein are pharmaceutical formulations comprising particles of formula 1: | 2011-01-27 |
20110020454 | NOVEL DOSAGE AND FORMULATION - The present disclosure relates to pharmaceutical compositions for inhalation comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier, providing a metered nominal dose of aclidinium equivalent to about 200 micrograms aclidinium bromide. | 2011-01-27 |
20110020455 | SOLID DISPERSION AND PHARMACEUTICAL COMPOSITION OF THE SAME, AND PRODUCTION PROCESSES THEREOF - A powdery porous carrier comprising a porous silicon-containing carrier is impregnated with a solution containing an organic solvent and an active ingredient hardly soluble in water, and the organic solvent is removed to give a solid dispersion having the active ingredient supported to the porous carrier without a treatment with a supercritical fluid. The porous silicon-containing carrier has a heating loss of not more than 4% by weight at a temperature of 950° C. for 2 hours (e.g., a spherical silicon-containing carrier such as a spherical porous silica). The porous silicon-containing carrier may be a spherical silica having a mean pore size of 10 to 40 nm and an oil absorption of 175 to 500 ml/100 g. A pharmaceutical composition (e.g., tablets, granules, or capsules) may be prepared from the solid dispersion and a pharmaceutically acceptable carrier. This invention provides a solid dispersion and a pharmaceutical composition (or a pharmaceutical preparation) which allows improvement in a solubility and a bioavailability of an active ingredient hardly soluble in water (e.g., a fibrate compound). | 2011-01-27 |
20110020456 | LANTHANUM COMPOSITION - The present invention discloses stable, solid oral pharmaceutical composition comprising Lanthanum carbonate having more than 6 molecules of water per molecule of lanthanum carbonate and pharmaceutically acceptable carriers or diluents, wherein said carrier or diluent excludes monosaccharide/s or disaccharide/s, such that the composition has comparable in-vitro dissolution profile similar to that of FOSRENOL®. | 2011-01-27 |
20110020457 | POLYMER-SURFACTANT NANOPARTICLES FOR SUSTAINED RELEASE OF COMPOUNDS - A polymer-surfactant nanoparticle formulation, using the anionic surfactant aerosol OT (AOT) and polysaccharide polymer alginate, is used for sustained release of water-soluble drugs. The AOT-alginate nanoparticles are suitable for encapsulating doxorubicin, verapamil and clonidine, as well as therapeutic agents effective against dermal conditions such as psoriasis. The nanoparticles are also suitable for encapsulating photo-activated compounds such as methylene blue for use in photo-dynamic therapy of cancer and other diseases, and for treating tumor cells that exhibit resistance to at least one chemotherapeutic drug. | 2011-01-27 |
20110020458 | SUSTAINED-RELEASE COMPOSITION OF DRUGS ENCAPSULATED IN MICROPARTICLES OF HYALURONIC ACID - A sustained-release drug composition consisting essentially of microparticles of hyaluronic acid having a high molecular weight or an inorganic salt thereof and a protein or peptide drug encased in said microparticles, wherein the average size of said microparticles ranges from 0.1 to 40 μm. | 2011-01-27 |
20110020459 | Microfluidic method and system for isolating particles from biological fluid - The invention relates to a system and method for isolating particles from a biological fluid, including: obtaining a sample of biological fluid from a source (e.g. a patient) in which the sample contains particles of multiple sample particle types; tagging particles in the sample with tagging agents, including mixing the sample with a solution of magnetic tagging agents that selectively bind to particles of at least one of the sample particle types, thereby forming a group of tagged particles in the sample; passing the sample through a magnetic conduit having a magnetic field that interacts with at least some of the tagged particles; sorting the particles of the sample into multiple groups based on the interaction between the tagged particles and the magnetic field; and optionally returning selected portions of the processed fluid back to its source with or without the addition of appropriate therapeutic agents. | 2011-01-27 |
20110020460 | GPR 119 MODULATORS - Compounds of Formula I that modulate the activity of the G-protein-coupled receptor GPR119 and their uses in the treatment of diseases linked to the modulation of the G-protein-coupled receptor GPR119 in animals are described herein. | 2011-01-27 |
20110020461 | HYALURONATE AND COLOSTRUM COMPOSITIONS AND METHODS OF USING THE SAME - The present disclosure includes disclosure of various embodiments of composition comprising a therapeutically-effective amount of a hyaluronate and a therapeutically-effective amount of colostrum. In at least one embodiment, the hyaluronate comprises sodium hyaluronate, and the colostrum comprises bovine colostrum. In an exemplary method of reducing osteoblastic activity within a warm-blooded vertebrate, the method comprises the step of administering a composition comprising a therapeutically-effective amount of a hyaluronate and a therapeutically-effective amount of colostrum to the warm-blooded vertebrate. | 2011-01-27 |
20110020462 | NEW USE OF HISTONE DEACETYLASE INHIBITORS IN CHANGING MRJP3 PROTEIN IN ROYAL JELLY - The invention provides a method of changing a ratio of 68 to 64 kDa protein of MRJP3 in a royal jelly, a method of producing a royal jelly comprising MRJP3 having a changed ratio of 68 to 64 kDa protein relative to a control royal jelly and the royal jelly produced thereform. Also provided is a method of promoting the growth of the larva of a queen bee comprising feeding the larva of the queen bee a royal jelly of the invention. Further provided is a method of producing bee larva, pupa and queen bees with sizes larger than normal. | 2011-01-27 |
20110020463 | THERAPEUTIC AGENT FOR FIBROMYALGIA SYNDROME AND THERAPEUTIC AGENT FOR PAIN CAUSED BY MUSCLE SPASM - A therapeutic agent for fibromyalgia syndrome or therapeutic agent for pain caused by vascular smooth muscle spasm including a) one or more compounds selected from a group consisting of RNA, ribonucleotide and ribonucleoside, b) one or more compounds selected from a group consisting of L-arginine, L-citrulline and L-ornithine, and c) L-ascorbic acid in which the mass ratio of Component b):Component c) is 1:0.2 to 20 is provided. | 2011-01-27 |
20110020464 | METHODS OF TREATMENT USING THYMUS-DERIVED COMPOSITIONS - Embodiments of the present invention provide processes for preparing thymus extracts and plant or fungal extracts, and more particularly provide compositions (Thyex-1-6A and -6B) produced in accordance with said processes, and methods for treatment of various conditions comprising administration of said compositions including but not limited to impaired physical vigor or aptitude, and aging and/or age-related conditions (arthritis, mobility deficits, loss of appetite, etc.). Additional aspects provide methods for building muscle mass, for reducing exercise recovery period, or for sustaining exercise intensity. Particular aspects relate to preparation of | 2011-01-27 |
20110020465 | METHODS OF TREATMENT OF GOUT USING THYMUS-DERIVED COMPOSITIONS - Embodiments of the present invention provide processes for preparing thymus extracts and plant or fungal extracts, and more particularly provide compositions (Thyex-1-6A and -6B) produced in accordance with said processes, and methods for treatment of various conditions comprising administration of said compositions including but not limited to arthritis and/or arthritis-related conditions, including: gout, rheumatoid arthritis (RA), osteoarthritis (OA), and pseudogout, and/or inflammation resulting from any of the conditions Additional aspects provide methods for combination or adjunctive therapies (with anti-inflammatories, etc.). Methods to modulate immune response are also encompassed. | 2011-01-27 |
20110020466 | FERTILIZED EGG ISOLATE AND USE THEREOF - Fertilized egg isolate, methods for preparing the fertilized egg isolate and uses thereof for treating mental health disorders and disease or conditions mediated by or associated with one or more glutamate receptors or by the neurokinin 2 (NK2) receptor. | 2011-01-27 |
20110020467 | Inhibition of Biogenic Sulfide Production Via Biocide and Metabolic Inhibitor Combination - Biogenic sulfide production is synergistically inhibited by treating sulfate-reducing bacteria (SRB) with a biocide and a metabolic inhibitor. The biocide directly kills a first portion of the SRB. The metabolic inhibitor inhibits sulfate-reducing growth of a second portion of the SRB without directly killing the second portion of the SRB. The treatment of SRB with both a biocide and a metabolic inhibitor provides effective biogenic sulfide inhibition at significantly lower concentrations than would be required if the biocide or metabolic inhibitor was used alone. | 2011-01-27 |
20110020468 | Silver Oxide Formulations Having Improved Whiteness Characteristics - A topical formulation for application to exposed body tissue, the formulation comprising a silver(II) oxide and zinc oxide, intimately dispersed within a carrier medium. | 2011-01-27 |
20110020469 | AMINOPYRIMIDINES USEFUL AS KINASE INHIBITORS - The present invention relates to compounds useful as inhibitors of Aurora protein kinases. The invention also provides pharmaceutically acceptable compositions comprising those compounds and methods of using the compounds and compositions in the treatment of various disease, conditions, and disorders. The invention also provides processes for preparing compounds of the invention. | 2011-01-27 |
20110020470 | METHODS AND COMPOSITIONS FOR TREATING CANCER - In one aspect the present invention provides methods for treating cancer in a mammal, including the step of administering to a mammal suffering from a cancer an amount of ebselen that is sufficient to inhibit the growth of the cancer. In another aspect, the present invention provides methods for enhancing the chemotherapeutic effect of a platinum-containing chemotherapeutic agent administered to a mammal suffering from cancer. | 2011-01-27 |
20110020471 | ERYTHROCYTE ATP-RELEASE MODULATORS - Erythrocyte ATP-release modulators and composition and methods for their use to potentiate serum glucose clearance and vasodilation; methods for prophylactic or palliative therapy of glucose processing or vascular disorders; processes for preparing the modulators and compositions comprising them; and kits therefor. | 2011-01-27 |
20110020472 | NON-AQUEOUS GENERATION OF CHLORINE DIOXIDE - Disclosed is a method of making a non-aqueous chlorine dioxide solution by combining a chlorite salt and a non-aqueous carboxylic acid and the non-aqueous chlorine dioxide solution made by this method. Also disclosed are methods of disinfecting an object by applying the non-aqueous chlorine dioxide solution to the object and methods of disinfecting a liquid by adding the non-aqueous chlorine dioxide solution to the liquid. | 2011-01-27 |
20110020473 | CHLORINE DIOXIDE SOLUTION COMPOSITION - There are provided a chlorine dioxide solution composition whose solute includes dissolved chlorine dioxide and chlorite; and a solution composition encapsulating body including a glass vessel or enameled vessel and the chlorine dioxide solution composition hermetically sealed therein. | 2011-01-27 |
20110020474 | Methods of Treating Infections of the Nail or Skin Using Hypohalite - The present application discloses a method of treating or preventing an infection of a nail, claw, hoof, or skin comprising administering a pharmaceutically acceptable formulation comprising hypohalite and a formulating agent to a subject in need thereof, and compositions thereof. | 2011-01-27 |
20110020475 | CARDIOPLEGIC SOLUTION - The present invention relates to a new cardioplegic solution to arrest and protect the heart muscle during surgery. The cardioplegic solution according to the invention offers several significant advantages as compared to standard available solutions, and contains magnesium sulfate heptahydrate, potassium chloride, procaine hydrochloride and xylitol. | 2011-01-27 |
20110020476 | Composition based on vegetal extracts of ajuga reptans for preventing hair loss, stimulating the growth of hair, regulating the production of sebum - The present invention relates to preparations based on vegetal extracts of | 2011-01-27 |
20110020477 | ORAL PREPARATION, INJECTION PREPARATION, EXTERNAL SKIN PREPARATION AND COSMETIC METHOD FOR PREVENTING OR IMPROVING WRINKLES - Wrinkles are improved by applying an oral preparation, injection preparation or external skin preparation having a substance that controls heparanase as an active ingredient thereof. | 2011-01-27 |
20110020478 | METHOD FOR TREATING NEURAL INJURIES - A method for treating neural damage with a composition prepared from roots of | 2011-01-27 |
20110020479 | METHODS FOR MODULATING EICOSANOID METABOLISM - The inventive subject matter relates to methods for modulating an eicosanoid metabolic process in cells of an animal in need thereof, which comprises administering to the animal an amount of the inventive compositions effective for regulating the activity of an eicosanoid oxygenase. In particular, the inventive subject matter relates to methods for modulating arachadonic acid metabolism by administering an amount of the inventive compositions effective for regulating the activity of lipoxygenases and cyclooxygenases. | 2011-01-27 |
20110020480 | USE OF BENZOXAZINOIDS-CONTAINING CEREAL GRAIN PRODUCTS FOR HEALTH-IMPROVING PURPOSES - The invention relates to the use of benzoxazinoids-containing grains of cereals for the production of food and beverage products with health-improving effects. Especially the invention relates to the use of benzoxazinoids-containing grains of cereals for the production of bread baked on rye grains, wheat, spelt, rye and/or spelt sprouts for health-improving purposes. The health-improving effects according to the invention are obtained through the CNS stimulating effects of said benzoxazinoid-containing food and beverage products. These effects are appetite suppression, enhancement of mood, improved sexual function, relieve of fibromyalgia and sleep apnea disorders. Other CNS-related disorders are included as well. The health-improving effects of the invented food products containing benzoxazinoids also include anti-cancer activity, anti-inflammatory effects, analgesic effects and antibacterial effects. The total content of benzoxazinoids was maintained in the bread through the baking process and it can be calculated that the daily amount of rye bread needed to obtain a CNS-stimulating effect is about 1.5-240 g. | 2011-01-27 |
20110020481 | Swinglea glutinosa LEAVES DERIVED MATERIAL IN COMBINATION WITH AVERMECTINS FOR CONTROL OF ACARI - The invention of the present application provides a natural material derived from | 2011-01-27 |
20110020482 | APPARATUS FOR TRANSFERRING DOSES OF PLASTIC MATERIAL - An apparatus includes a transferring arrangement arranged for delivering doses of plastic material to a compression-molding device. The transferring arrangement includes a containing arrangement arranged for receiving the doses and a movement-promoting arrangement received in the containing arrangement and movable with respect to the containing arrangement for delivering the doses to the compression-molding device. The movement-promoting arrangement is made at least partially of a porous material. | 2011-01-27 |
20110020483 | VENTED MOLD AND METHOD FOR PRODUCING MOLDED ARTICLE - The invention relates mold, particularly a mold for producing foam articles. In a preferred embodiment, the mold comprises a lid and a bowl releasingly engageable to define a mold cavity, the lid comprising: (i) a vent having a passageway for gas to escape from the mold cavity, and (ii) a plurality of grooves connected to the vent. The use of a plurality of grooves/slots in the mold cavity surface effectively acts as a siphon to draw gas away from the composition to be molded. The plurality of grooves/slots is connected to one or more vents which then allows for escape of the gas from the mold cavity to the exterior of the mold. | 2011-01-27 |
20110020484 | Barrier Guard for Dough Sheeter - A guard member for use with a dough sheeter having a shut-off mechanism includes a first portion structured to be coupled at or near a dough feed opening of the dough sheeter and a second portion coupled to the first portion. The second portion having a front face and an opposite rear face, the rear face being structured to engage and activate the shut-off mechanism when contact is made with the front face by an outside force. | 2011-01-27 |
20110020485 | Molding Machine - The invention is to provide a molding machine which has a drive system miniaturized and having high responsibility to start control, suspension control, acceleration control and deceleration control so that products can be molded with higher efficiency. A molding machine of a direct drive system for transmitting rotary power of an electric motor | 2011-01-27 |
20110020486 | DEVICE FOR FORMING FILM - A device for forming films on a substrate includes a main chamber and a reacting device. The main chamber is for receiving the substrate. The reacting device is received in the main chamber facing the substrate. The reacting device includes a reacting container, a supporting plate, a cover, and a collimation tube. The supporting plate and the cover are disposed on opposite ends of the reacting container to close the reacting container. The supporting plate is configured for supporting a target. The collimation tube is located in the reacting container to divide the reacting container into a first chamber and a second chamber. The target is located in the first chamber, and the cover defines a number of through holes. | 2011-01-27 |
20110020487 | MULTI-CAVITY MOLD - A multi-cavity mold includes a female die and a male die for molding products with the female die. The female die core includes a female die body and a number of female die cores received in the female die body. The male die consists of a male die body, a number of male die cores each corresponding to one female die core received in the male die body, and an ejection member. The male die body consists of a first plate, a second plate connected to the first plate, and a plurality of restricting plates corresponding to the plurality of male die cores. The first plate defining a number of male die cavities each receive a corresponding male die core therein. The restricting plates are fixed onto the first plate and configured to restrict the male die cores in the corresponding male die cavities. | 2011-01-27 |
20110020488 | APPARATUS FOR FABRICATING ELECTROLUMINESCENT DISPLAY DEVICE - The apparatus for fabricating an organic electroluminescent device which can distribute stress applied to the mask uniformly to form precise and reliable light emitting layers is disclosed. The apparatus for fabricating an electroluminescent device according to the present invention comprises a plurality of grippers disposed in a zigzag state at a periphery of a mask for clamping the mask, a plurality of jaws formed on each gripper and contacting with the mask, and power supplying units for supplying power to the grippers to stretch the mask. Each of the grippers is divided into a connecting section connected to the power supplying unit and a head section integrated into the connecting section, and a plurality of jaws are formed on the head section of each gripper, and odd (or even)-numbered grippers disposed at each side of the mask are disposed in a more forward position than even (or odd)-numbered grippers. Accordingly, the head section of each even (or odd)-numbered gripper is placed between the connection sections of two adjacent odd (or even)-numbered grippers. The head sections of even-numbered grippers and the head sections of odd-numbered grippers are arranged alternatively in two different imaginary lines. Also, the jaws are arranged in a line on the head section of each gripper or are arranged in a zigzag state on the head section of each gripper. At this time, the jaws are arranged by equal distance from each other. | 2011-01-27 |
20110020489 | Method for forming and selling candles - A method and apparatus (“utility”) for quickly and conveniently melting and blending candle materials to form a candle is provided. The utility utilizes a heated inclined surface on which the candle materials may be placed to melt. The melted candle materials may be directed into a candle mold. The utility includes a drip spout for directing the candle materials into a candle mold. A method for providing consumers with the opportunity to make individualized candles is also provided. The method includes enticing consumers to make their own candles, as well as providing an apparatus and/or materials to make candles. The apparatus and candle materials may be purchased and/or rented by consumers. | 2011-01-27 |
20110020490 | Demolding device for injection molding part with undercut - An apparatus for releasing a part that has an undercut, particularly in an injection molding system. A flange is moveably mounted with respect to a moveable part of an injection mold. A head is moveably mounted with respect to the moveable part. A joint, such as a ball-and-socket joint, is used to connect the head with respect to the flange. The head has a shoulder that contacts a stop which is longitudinally fixed with respect to the moveable part, when the mold is in a closed position. A bias element can be used to normally urge the head in a lateral direction with respect to the moveable part. | 2011-01-27 |
20110020491 | REDUCED STUCK ALCOHOLIC FERMENTATIONS IN WINE PRODUCTION - A method for production of a wine wherein the method significantly decreases the risk of unwanted stuck alcoholic fermentations. The method involves addition of glucose isomerase to the grape juice. | 2011-01-27 |
20110020492 | System and method for preparing naan bread - A method and system for preparing naan bread is provided. A conveyor oven is used to bake flattened and pre-shaped naan bread loaves. The conveyor oven uses high temperature gas heat to bake the naan, imparting traditional characteristics such as the slightly smoky or scorched appearance. The oven interior is preferably lined with stone, granite, clay or porcelain to enhance baking and provide traditional flavour. | 2011-01-27 |
20110020493 | Method For Manufacturing Korean Hot Pepper Paste Using Watermelon - Provided is a method for manufacturing Korean hot pepper paste using watermelon, and more particularly, a method for manufacturing Korean hot pepper paste using watermelon without using water and syrup, or sugar, which is a method for manufacturing a healthful watermelon hot pepper paste by adding glucose, fructose, and amino acid flavor that watermelon contains to eliminate the unpleasant odor that meju (Korean-style dried, fermented soybeans formed in brick-shaped clusters) powder has in traditional Korean hot pepper paste, adding taste with sugars contained in watermelon, and highlighting the color of the hot pepper paste using a lycopene ingredient. | 2011-01-27 |
20110020494 | GROWTH MEDIUM FOR LACTIC ACID BACTERIA - The present invention provides lactic acid bacterial cultures. In some particularly preferred embodiments, the present invention provides cultures comprising lactic acid bacteria, a dairy substrate (e.g., milk or cream), at least one formate source, and at least one purine source. In some further embodiments, the cultures comprise exogenous lactase enzyme. The present invention also provides cultures of cells comprising the culture medium and lactic acid bacteria. The present invention further provides starter compositions (i.e., starter cultures) for starting the culture. In some embodiments, the compositions of the present invention find use in the production of fermented milk products (e.g., yogurt, cheese and/or fermented milk beverages). | 2011-01-27 |
20110020495 | Cream Cheese and Method of Manufacture - A method for making a high fat cream cheese product with enhanced creamy texture. A milk source and an optional fat source can be combined to form a standardized milk base having a first fat level of about 7% or less, which is then inoculated with a bacteria starter culture and fermented. After fermentation, an optional pH adjustment step may be provided, and the pH may be adjusted by addition of a sweet (i.e., unfermented) mix. The fermented milk base is then ultrafiltered, and an ultrafiltration concentrate results having a second fat level greater than the first fat level and up to about 20%. The ultrafiltration concentrate is combined with a sour cream having a fat content greater than about 20%, and the combined mixture is then heated, homogenized, and packaged resulting in a high fat cream cheese product having a fat content greater than about 20%. | 2011-01-27 |
20110020496 | BRANCHED DEXTRIN, PROCESS FOR PRODUCTION THEREOF, AND FOOD OR BEVERAGE - A branched dextrin insusceptible to digestion and having a low osmotic pressure, as well as a method for producing such a branched dextrin is provided. The branched dextrin characterized by having a structure wherein glucose or isomalto oligosaccharide is linked to a non-reducing terminal of a dextrin through an α-1,6 glucosidic bond and having a DE of 10 to 52. A method characterized in that, in a method for producing a branched dextrin by allowing maltose-generating amylase and transglucosidase to act on an aqueous dextrin solution, the maltose-generating amylase and transglucosidase are adjusted so as to attain an enzyme unit ratio of 2:1 to 44:1 and allowed to act. | 2011-01-27 |
20110020497 | CAPSULE CONTAINING NUTRITIONAL INGREDIENTS AND METHOD OF DELIVERY OF A NUTRITIONAL LIQUID FROM THE CAPSULE - The invention proposes a capsule ( | 2011-01-27 |
20110020498 | (ARABINO)XYLAN OLIGOSACCHARIDE PREPARATION - The present invention relates to preparations comprising (arabino)xylan oligosaccharides with average degree of polymerisation between 4 and 10 and average degree of arabinose substitution between 0.15 and 0.35, which beneficially modulate the intestinal flora, such preparation comprising both xylo- and arabinoxylo-oligosaccharides. Preferably, the arabinoxylooligosaccharides are substituted in part by hydroxycinnamic acids and exert antioxidant effects. Furthermore, it is preferred that the preparations according to the present invention have a nitrogen content below 0.16% (w/w) in order to ensure good organoleptic and colour properties, particularly upon heating said preparations. In addition, food, beverage and nutritional supplement products comprising the preparations are provided as well as methods to prepare the said preparations. | 2011-01-27 |
20110020499 | CAPSULE FOR INFUSION BEVERAGES - The invention relates to a capsule and a device for preparing an infusion beverage, such as coffee, tea, or milk beverages. The capsule comprises two parallel extending wall sections, which are connected to each other by a sealing connection. A pressurized liquid or gaseous medium can be conducted through an access to the sealing connection of the capsule with the aid of a supply line in a holder of the device such that the sealing connection is partially undone. As a result, an opening is produced in the capsule. An infusion fluid can be conducted through said opening, wherein the fluid can then become mixed with a powder or granules present in the capsule into an infusion beverage. Said infusion beverage can be discharged through a further opening. In this method for opening the capsule, no objects or parts of the device come in contact with the infusion fluid or the infusion beverage. As a result, contamination is prevented. In addition, there are fewer wear parts, such as needles or blades, which could become dull. | 2011-01-27 |
20110020500 | CAPSULE WITH FLOW CONTROL AND FILTERING MEMBER - A sealed capsule contains a beverage ingredient in powder form, in particular, ground coffee. The capsule comprises a base body ( | 2011-01-27 |
20110020501 | Fiber Enriched, Protein Coated Cereal Products - A cereal product comprising cereal kernels, wherein the cereal kernels have been at least partially milled and are coated with a coating layer, said coating layer comprising a protein matrix having particles of a dietary fiber ingredient dispersed therein. Also provided is a method of making a fiber-enriched dry cereal product comprising the steps of: coating cereal kernels that have been at least partially milled with particles of a dietary fiber ingredient and an aqueous dispersion containing a protein; followed by drying the coated cereal kernels. The dietary fiber ingredient may be a powdered stabilized cereal bran. The coated cereal products can be cooked in excess water to give cooked products having high dietary fiber content and improved palatability. | 2011-01-27 |
20110020502 | CHOCOLATE AND PEANUT BUTTER SLURRY TOPICAL COATING FOR SNACK PRODUCTS - Chocolate flavored compound coating and nut butter based coated snack products are provided whose coatings are resistant to rub-off or oiling out of the nut oil constituent as well as methods for preparing such coated snack products. The present methods include a first step of providing a hot (˜32 to 44° C.), chocolate and creamy nut butter coating slurry. The methods include a second step of applying the hot coating to a food base to provide a liquid coating coated food base in a weight ratio of coating to food base ranging from ˜1:10 to ˜1:1. The methods include a third step of applying sufficient amounts of a dry particulate setting sugar to a quantity of liquid hot slurry coated food base pieces to provide a finished dry stabilized non-sticky powdered coated food base. | 2011-01-27 |
20110020503 | AGGLOMERATES AND PREPARATION THEREOF - Agglomerates of cereals are held together by a binding matrix, rather than sugars, and are formed by providing a dry mix of cereals in particular form, such as flakes, and starch-based matrix—forming material, optionally along with other components. These are then mixed with water to hydrate the binding matrix and allow it to swell to form a paste and to bind the bulk materials together. The resulting blend is extruded to an outlet using a relatively open or no die so that any back pressure and heat generated is sufficient to permit the matrix material to set and bind the particular cereal without excess heat. The agglomerate extruded from the extruder are cut into pieces of the desired size and dried to final desired moisture content. | 2011-01-27 |
20110020504 | Crispy Jalapeno - A method of making crispy pepper chips includes providing a pepper. The method also includes slicing the pepper to form pepper slices. The method also includes cooking and dehydrating without burning to form crispy pepper chips. | 2011-01-27 |
20110020505 | PACKAGE FOR MOLDED FOOD PRODUCT - A solid food product is molded in a mold cavity and is thereafter packaged in the mold cavity. The mold cavity is formed in a sheet and includes a side wall which extends from the sheet and a bottom wall which includes an inverting portion which extends from said side wall and a central portion. The central potion of the bottom wall includes a plurality of ridges which form a decorative design. A liquid food product is introduced into the mold cavity and allowed to solidify to form a molded solid food product. The central portion of the bottom wall is thereafter pushed into the mold cavity to invert said inverting potion and to push the molded food product away from the central portion of the bottom wall. The molded food product includes ridges which correspond to the ridges in the bottom wall of the mold cavity. A lid is attached to the sheet to enclose and package the molded food product within the mold cavity. | 2011-01-27 |
20110020506 | Packaged Frozen Ready-Made Meal - Packaged frozen ready-made meal including a flared receptacle made of a rigid material permeable to microwaves, containing a first frozen food component at the bottom, a second frozen food component having a substantially plate-like shape, having a substantially fluid consistency at a temperature above 0° C., and a closure element, wherein the second frozen food component having a substantially plate-like shape is engaged in the manner of a plug with the internal wall of the receptacle, spaced apart from the first frozen food component. | 2011-01-27 |
20110020507 | PROTEIN STABILIZER SYSTEMS COMPRISING CARRAGEENAN FOR WEAKLY ACIDIC FLAVORED MILK DRINKS - Mildly acidic milk and soy beverages and methods for preparation of mildly acidic milk and soy beverages are provided herein. The acidified milk and soy beverages generally comprise a milk product and a stabilizer system at a mildly acidic pH in the range of about 5.0 to about 6.0. In particular embodiments, the beverage further comprises one or more components to provide a fruit flavor to the acidified milk beverage. In embodiments, the acidified milk and soy beverages comprise a milk product in an amount sufficient to provide milk protein and/or soy protein in the beverage in an amount from about 0.25% by weight to about 4.0% by weight of the beverage and a stabilizer system comprising a carrageenan component and optionally a high acyl gellan gum. The carrageenan component desirably comprises a mildly extracted kappa-iota copolymer with minimal alkaline modification. | 2011-01-27 |
20110020508 | Select Serving and Flavored Sparkling Beverage Maker - The present invention relates generally to method and a device to make a single or a multiple repeated single servings of a select flavored, carbonated beverage. The instant abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way. | 2011-01-27 |
20110020509 | USE OF MAGNETIC, IONIC LIQUIDS AS AN EXTRACTION AGENT - The invention relates to a method which uses magnetic ionic liquids for the liquid-liquid, liquid-solid, or liquid-gas extraction, wherein the partition of the phases occurs in a magnetic field. | 2011-01-27 |
20110020510 | AQUEOUS DISPERSION OF FRUCTAN-CONTAINING PARTICLES, METHOD OF PREPARATION AND USE - The invention relates to an aqueous dispersion of fructan-containing particles, wherein the D | 2011-01-27 |
20110020511 | CONTAINERS AND METHODS FOR REDUCING OR ELIMINATING BACTERIA IN CONSUMABLE EGGS - Methods and containers suitable for reducing or eliminating bacteria such as | 2011-01-27 |
20110020512 | METHOD FOR ENHANCING FORM RETENTION PROPERTY OF BEVERAGE - The present invention provides a method for enhancing a foam retention property of a beverage, and in addition a method for stably retaining foam in a beverage, the foam obtained by shaking the beverage, by enhancing the foam retention property. The present invention is implemented by preparing a beverage by using a fermentation-derived cellulose as a raw material thereof, more preferably by preparing a beverage by using a fermentation-derived cellulose in a state of complex with a high molecular substance. | 2011-01-27 |
20110020513 | APPARATUS AND METHOD - A form-fill-seal packaging machine includes a tank ( | 2011-01-27 |
20110020514 | PNEUMATIC SEASONING SYSTEM - A pneumatic seasoning system and method utilizing a rotating drum for seasoning, a funnel-fed pneumatic eductor, line splitters, and a plurality of specially-designed swirl-inducing nozzle spools for inducing a broad and even seasoning plume. In a preferred embodiment, a pneumatic seasoning system transports seasoning from a seasoning hopper to food items within a rotating drum using a combination of an eductor and four in-line vacuum generators, which vacuum generators operate on compressed air. Each vacuum generator comprises a distributing nozzle roughly shaped like a collared spool, wherein compressed air is supplied to the annular region defined between the spool and its collar, and said compressed air exits through swirl ports distributed about the circumference of the spool exit. Each swirl port preferably has a pitch angle of 15° and a yaw angle of 15°. | 2011-01-27 |
20110020515 | FROZEN BEVERAGE DEVICE - A frozen beverage device ( | 2011-01-27 |
20110020516 | JASMINUM SAMBAC-LIKE FRAGRANCE COMPOSITION - The present invention provides a flavor and/or fragrance composition having a natural scent of | 2011-01-27 |
20110020517 | TASTE MODIFYING PRODUCT - The present invention relates to the use of an alkylpyridine of formula (I) wherein R represents a cyclic alkyl or alkenyl group as taste-conferring or enhancing ingredient to impart or reinforce the kokumi or umami taste in flavored compositions or flavored foods. | 2011-01-27 |
20110020518 | TASTE MODIFYING PRODUCT - The present invention relates to the use of alkylpyridines of formula (I) wherein R represents a C | 2011-01-27 |
20110020519 | ENCAPSULATION OF OXIDATIVELY UNSTABLE COMPOUNDS - An encapsulated material is formed by congealing droplets of a molten blend of oxidatively unstable material and phytosterol in a chilling gas stream to form prilled cores containing oxidatively unstable material and phytosterol, and encapsulating the prilled cores in one or more protective shell layers to form free-flowing microparticles. | 2011-01-27 |
20110020520 | Encapsulation of readily oxidizable components - A stabilized emulsion is mixed with plasticizable matrix material to produce shelf stable, controlled release, discrete, solid particles or pellets which contain an encapsulated and/or embedded component, such as a readily oxidizable component, such as omega-3 fatty acids. An oil encapsulant component which contains an active, sensitive encapsulant, dissolved and/or dispersed in an oil is admixed with an aqueous component and a film-forming component, such as a protein, to form an emulsion. The emulsion is admixed with a matrix material for obtaining a formable mixture or dough. An acidic antioxidant for prevention of oxidation of the active, sensitive encapsulant, and a plasticizer which solubilizes the acidic antioxidant are included in the matrix material which encapsulates film-coated oil droplets containing the readily oxidizable component. The plasticizer, such as glycerol, provides mobility for the acidic antioxidant within the matrix material of the pellets for reaction with any ambient oxygen and malodorous amines. | 2011-01-27 |
20110020521 | Method For Manufacturing Jam Using Watermelon - Provided is a method for manufacturing jam using watermelon, and more particularly, with respect to storability, processibility, manufacturing economy, productivity; use of additives, etc., a new method for manufacturing jam, which is required to manufacture uniform quality watermelon jam which maintains a suitable quality by quantifying the parameters, is constant and stable, and satisfies the palates of average consumers. | 2011-01-27 |
20110020522 | PROCESS FOR PRODUCING GRANULAR LOW-CALORIE FOOD MATERIAL AND RAW MATERIAL FOR PRODUCING THE SAME - A process for producing a granular low-calorie food material comprising the steps of forming a composition into granules, and drying the granules, | 2011-01-27 |
20110020523 | Method for Preparing a Low Viscosity Whole Grain Flour Slurry Via Mechanical Treatment - A method for preparing a low viscosity whole grain flour slurry including hydrating whole grain flour in water and subjecting the flour-water mixture to mechanical treatment to obtain a low viscosity whole grain flour slurry. | 2011-01-27 |
20110020524 | Tofu coagulant and process for producing the same - A method for producing tofu coagulant includes a mineral salt solution as water phase (tank T | 2011-01-27 |
20110020525 | CITRUS PULP FIBER DRY BLEND SYSTEMS - There is disclosed a dry blend system comprising citrus pulp fiber; and at least one component selected from the group consisting of hydrocolloids, lipids, carbohydrates, and proteins, wherein the dry blend system is capable of replacing the solids content in a finished food product. | 2011-01-27 |
20110020526 | CORN PLANTS AND SEED ENHANCED FOR ASPARAGINE AND PROTEIN - The present invention relates to a corn plant and seed with enhanced levels of protein and amino acids. The invention also relates to DNA constructs that provide expression in transgenic corn cells of an asparagine synthetase enzyme. The DNA constructs are used in a method to produce transgenic corn plants and seeds and to select for plants and seeds with enhanced levels of protein and amino acids. | 2011-01-27 |
20110020527 | CONCENTRATE PASTE FOR DIPS/SPREADS AND PROCESS FOR THEIR PREPARATION - An edible paste concentrate consisting of ground chickpeas, cooked and dried, and crushed sesame seeds is provided. The paste has a shelf life of at least three months, and when mixed with water, provides a dip or a spread with the flavor and texture of freshly prepared hummus. Also provided is a process for manufacturing a spread or a dip from chickpeas or other legumes. | 2011-01-27 |
20110020528 | YEAST MUTANT AND YEAST EXTRACT - A natural yeast extract which is rich in glutamic acid and therefore has an impact at first taste. Further, provided is a yeast extract which is also rich in 5′-guanylic acid or 5′-inosinic acid and therefore has strong umami. Further, provided is a yeast mutant capable of accumulating a large amount of glutamic acid, glutamine and ribonucleic acid for obtaining such a yeast extract. A yeast mutant to which resistance to organic acids and analogues thereof has been imparted by inducing spontaneous mutation, accumulates a significant amount, i.e., 10% by weight or more of the total of free glutamic acid and glutamine in the cell, and further accumulates 5% by weight or more of a ribonucleic acid. The yeast extract produced by using this strain contains 20% by weight or more of L-glutamic acid, and further contains 3% by weight or more of 5′-IG. | 2011-01-27 |
20110020529 | Method For Manufacturing Starch Syrup Using Watermelon - Provided is a method for manufacturing starch syrup using watermelon, and more particularly, a new method for manufacturing starch syrup, with respect to storability, processibility, manufacturing economy, productivity, use of additives, etc., which is required to manufacture uniform quality starch syrup which maintains a suitable quality by quantifying the parameters, is constant and stable, and satisfies the palates of average consumers. | 2011-01-27 |
20110020530 | METHOD FOR MODIFYING STARCH AND METHOD FOR PRODUCING STARCH BLENDED PREPARATION - The present invention provides a method of effectively modifying starch so as to have an inhibitory effect on swelling and disintegration equivalent to that of chemically-linked starch, without using chemicals or a large amount of water. | 2011-01-27 |
20110020531 | Method for coating medical devices - An apparatus for coating medical devices at the point of care with a polymer and/or therapeutic agent comprising an environmentally controlled device coating chamber in which the device may be delivered by the manufacturer as the device packaging, or the device may be placed into the chamber at the point of care. The environmentally controlled chamber can provide a sterile enclosure in which the polymer and/or a therapeutic agent can be applied to an uncoated or previously coated device and converted to another form (such as a liquid to a film or gel) if desired, under controlled and reproducible conditions. The environmentally controlled chamber can accommodate and provide for coating the device by immersion, spray and other methods of covering the device surface with a liquid or powder. The chamber can provide for energy sources, both internally, such as heat produced by film heaters, and externally, such as UV light or microwave passing through the enclosure. The chamber may allow for changes in atmosphere to affect the coating, such as the introduction of certain gases and introducing pressure or vacuum. | 2011-01-27 |
20110020532 | PAPERMAKING COATING STATION WITH PRESSURE-SENSITIVE FILM ROLL - A counter roll ( | 2011-01-27 |
20110020533 | SCANNING PROBE-BASED LITHOGRAPHY METHOD - A resist medium in which features are lithographically produced by scanning a surface of the medium with an AFM probe positioned in contact therewith. The resist medium comprises a substrate; and a polymer resist layer within which features are produced by mechanical action of the probe. The polymer contains thermally reversible crosslinkages. Also disclosed are methods that generally includes scanning a surface of the polymer resist layer with an AFM probe positioned in contact with the resist layer, wherein heating the probe and a squashing-type mechanical action of the probe produces features in the layer by thermally reversing the crosslinkages. | 2011-01-27 |
20110020534 | BATTERY ELECTRODE MAKING METHOD - A manufacturing method of a battery electrode includes the following steps: providing a reducing reagent, a conductive adjuvant, and a solution comprising ferric ion, wherein the conductive adjuvant is selected from the group consisting of a metallic salt, a metal particle, a metal compound and a carbon conductive substance; applying the conductive adjuvant into the solution comprising ferric ion to form a first mixture solution, followed by mixing the first mixture solution with the reducing reagent to form a second mixture solution, wherein the conductive adjuvant and the ferric ion are reduced by the reducing reagent to form a composite micro-particle comprising iron micro-particle; isolating the composite micro-particle from the second mixture solution; providing an adhesive reagent and mixing with the composite micro-particle to form a coating reagent; and applying the coating reagent onto a metal mesh to produce the battery electrode. | 2011-01-27 |
20110020535 | SENSING ELEMENT AND METHOD OF MAKING THE SAME - Disclosed herein is a method of making a sensing element comprising forming an electrically conductive element, wherein the sensing element comprises a metal selected from the group consisting of Pd and alloys and combinations comprising Pd; and wherein the electrically conductive element is thermally stable at temperatures as high as 1,200° C. | 2011-01-27 |
20110020536 | ELECTRODE FOR LITHIUM SECONDARY BATTERY AND METHOD OF MANUFACTURING SAME - A production method of an electrode for a lithium-ion secondary battery includes: (A) a step of providing a current collector | 2011-01-27 |
20110020537 | WARM MIX ASPHALT BINDER COMPOSITIONS CONTAINING LUBRICATING ADDITIVES - The present invention provides a functionally dry warm mix asphalt binder composition modified with lubricating agents or additives that can be mixed with aggregate and compacted at temperatures substantially below asphalt binder compositions that do not contain the disclosed lubricating additives. | 2011-01-27 |
20110020538 | METHODS OF COATING CORE MATERIALS FOR PRODUCTION OF ARMOR SYSTEMS - An armor system and method involves providing a core material and a stream of atomized coating material that comprises a liquid fraction and a solid fraction. An initial layer is deposited on the core material by positioning the core material in the stream of atomized coating material wherein the solid fraction of the stream of atomized coating material is less than the liquid fraction of the stream of atomized coating material on a weight basis. An outer layer is then deposited on the initial layer by positioning the core material in the stream of atomized coating material wherein the solid fraction of the stream of atomized coating material is greater than the liquid fraction of the stream of atomized coating material on a weight basis. | 2011-01-27 |
20110020539 | PALLADIUM THIOLATE BONDING OF CARBON NANOTUBES - Carbon nanotube (CNT) arrays are attractive thermal interface materials with high compliance and conductance that can remain effective over a wide temperature range. Disclosed herein are CNT interface structures in which free CNT ends are bonded using palladium hexadecanethiolate Pd(SC | 2011-01-27 |